13F filerCIK 1061768 ↗
Baupost Group
You are looking at Q3 2020. See the latest, Q3 2026 →
Reported value
$9.25B
+15% on the quarter before
Positions
37
11 new, 5 sold out
Top 10
66.2%
of the value
Est. gain
−$6.1M
on stocks held all quarter
Est. return
−0.1%
on those stocks since Q2 2020
Positions as of Sep 30, 2020, from Baupost Group's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q2 2020. Striped tiles are options.
Largest buys
Since Q2 2020, sized at quarter-end prices.
- Pershing Square Tontine Hldg~$397.1MNew, 0.0% → 4.3% of the portfolio+17,500,000 shares
- Micron~$245.2MNew, 0.0% → 2.7% of the portfolio+5,222,000 shares
- Pg&E Corp~$243.7MAdded, 0.5% → 3.1% of the portfolio+25,955,158 shares
- Liberty Media Corp Del~$186.3MAdded, 0.1% → 2.1% of the portfolio+5,630,409 shares
- Ss&C Technologies Hldgs Inc~$174.8MAdded, 0.1% → 2.0% of the portfolio+2,887,993 shares
- Applied Materials~$137.1MNew, 0.0% → 1.5% of the portfolio+2,306,601 shares
- Healthpeak Properties Inc~$108.6MNew, 0.0% → 1.2% of the portfolio+4,000,000 shares
- Liberty Media Corp Del~$97.0MNew, 0.0% → 1.0% of the portfolio+2,923,048 shares
- Viasat Inc~$87.9MAdded, 6.6% → 6.1% of the portfolio+2,556,891 shares
- Verint Sys Inc~$80.6MAdded, 0.3% → 1.2% of the portfolio+1,673,672 shares
Largest sells
Since Q2 2020, sized at quarter-end prices.
- Akebia Therapeutics Inc~$203.7MSold out, 2.5% → 0.0% of the portfolio−15,000,000 shares
- Ebay Inc.~$102.7MCut, 21.0% → 17.0% of the portfolio−1,970,777 shares
- Hca Healthcare Inc~$97.1MSold out, 1.2% → 0.0% of the portfolio−1,000,000 shares
- Hp Inc~$89.3MCut, 3.9% → 2.7% of the portfolio−4,700,681 shares
- Alphabet~$88.3MCut, 3.8% → 2.5% of the portfolio−60,100 shares
- Meta~$75.6MCut, 2.4% → 1.6% of the portfolio−288,500 shares
- Amerisourcebergen Corp~$47.2MSold out, 0.6% → 0.0% of the portfolio−468,150 shares
- Univar Solutions Inc~$21.6MSold out, 0.3% → 0.0% of the portfolio−1,283,248 shares
- Ventas Inc~$20.1MSold out, 0.3% → 0.0% of the portfolio−550,000 shares
- Qorvo~$13.2MCut, 4.2% → 4.1% of the portfolio−102,200 shares
Holdings
As of Sep 30, 2020; changes in shares since Jun 30, 2020.
| Holding | Value | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Ebay Inc.COM · shares −6.1% · price −0.7% | 17.0% | $1.57B | −$10.5M | ||||||
| Liberty Global PlcSHS CL C · shares 0% · price −4.5% | 12.1% | $1.12B | −$53.2M | ||||||
| Fox CorpCL A COM · shares −1.3% · price +3.8% | 8.1% | $750.7M | +$27.2M | ||||||
| Viasat IncCOM · shares +19% · price −10.4% | 6.1% | $560.2M | −$54.7M | ||||||
| Viacomcbs IncCL B · shares 0% · price +20.1% | 5.7% | $527.6M | +$88.3M | ||||||
| Pershing Square Tontine HldgCOM CL A · shares New | 4.3% | $397.1M | — | ||||||
| QorvoCOM · shares −3.3% · price +16.7% | 4.1% | $382.2M | +$54.8M | ||||||
| Pg&E CorpCOM · shares +552% · price +5.9% | 3.1% | $287.9M | +$2.4M | ||||||
| Hd Supply Hldgs IncCOM · shares +3.0% · price +19.0% | 3.0% | $281.2M | +$43.6M | ||||||
| Hp IncCOM · shares −26% · price +9.0% | 2.7% | $252.6M | +$20.7M | ||||||
| Mckesson CorpCOM · shares 0% · price −2.9% | 2.7% | $248.6M | −$7.5M | ||||||
| MicronCOM · shares New | 2.7% | $245.2M | — | ||||||
| Translate Bio IncCOM · shares 0% · price −24.0% | 2.6% | $242.4M | −$76.7M | ||||||
| AlphabetCAP STK CL C · shares −28% · price +4.0% | 2.5% | $227.2M | +$8.7M | ||||||
| Liberty Media Corp DelCOM C SIRIUSXM · shares +3,046% · price −4.0% | 2.1% | $192.4M | −$253,610 | ||||||
| Nexstar Media Group IncCL A · shares 0% · price +7.5% | 2.0% | $187.5M | +$13.0M | ||||||
| Ss&C Technologies Hldgs IncCOM · shares +2,055% · price +7.2% | 2.0% | $183.3M | +$568,011 | ||||||
| Liberty Global PlcSHS CL A · shares 0% · price −3.9% | 1.7% | $160.9M | −$6.5M | ||||||
| Fox CorpCL B COM · shares 0% · price +4.2% | 1.7% | $158.9M | +$6.4M | ||||||
| MetaCL A · shares −34% · price +15.3% | 1.6% | $147.4M | +$19.6M | ||||||
| Applied MaterialsCOM · shares New | 1.5% | $137.1M | — | ||||||
| Theravance Biopharma IncCOM · shares −6.2% · price −29.6% | 1.4% | $129.1M | −$54.2M | ||||||
| Atara Biotherapeutics IncCOM · shares 0% · price −11.0% | 1.4% | $128.6M | −$16.0M | ||||||
| Verint Sys IncCOM · shares +272% · price +6.6% | 1.2% | $110.3M | +$1.8M | ||||||
| Healthpeak Properties IncCOM · shares New | 1.2% | $108.6M | — | ||||||
| Total 37 positions | 100% | $9.25B | −$6.1M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2020 to Q3 2020: 25 stocks held throughout, down $6.1M (−0.1%).
- Viacomcbs Inc+$88.3M+20%
- Qorvo+$54.8M+17%
- Hd Supply Hldgs Inc+$43.6M+19%
- Fox Corp+$27.2M+4%
- Hp Inc+$20.7M+9%
- Atara Biotherapeutics Inc−$16.0M−11%
- Liberty Global Plc−$53.2M−5%
- Theravance Biopharma Inc−$54.2M−30%
- Viasat Inc−$54.7M−10%
- Translate Bio Inc−$76.7M−24%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Nov 13, 2026 | $5.05B−7% | SEC ↗ |
| Q2 2026 | Aug 13, 2026 | $5.42B+6% | SEC ↗ |
| Q1 2026 | May 14, 2026 | $5.12B−3% | SEC ↗ |
| Q4 2025 | Feb 13, 2026 | $5.28B+10% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $4.79B+16% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $4.13B+18% | SEC ↗ |
| Q1 2025 | May 14, 2025 | $3.50B+2% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $3.43B−2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $3.52B−3% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $3.63B−0% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $3.65B−20% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $4.59B−12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $5.21B−7% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $5.61B−4% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $5.85B−5% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $6.13B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $5.79B−14% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $6.77B−27% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $9.30B−8% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $10.13B−7% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $10.88B−12% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $12.33B−2% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $12.56B+16% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $10.84B+17% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $9.25B+15% | SEC ↗ |
| Q2 2020 | Aug 13, 2020 | $8.01B+18% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $6.77B−25% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $9.06B+3% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $8.83B−20% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $11.05B−7% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $11.90B+3% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 | $11.52B−12% | SEC ↗ |
| Q3 2018 | Nov 15, 2018 (amended) | $13.06B+14% | SEC ↗ |
| Q2 2018 | Aug 13, 2018 | $11.44B+10% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $10.37B+3% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $10.11B+26% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $8.02B−8% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $8.75B+3% | SEC ↗ |
| Q1 2017 | May 25, 2017 (amended) | $8.49B+11% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $7.67B+9% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $7.04B−4% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $7.37B+6% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $6.92B | SEC ↗ |